ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2406

The Relationship Between Anti-Citrullinated Protein Antibodies and Radiographic Damage In African-Americans With Rheumatoid Arthritis

Maria I. Danila1, Richard J. Reynolds2, Stella Aslibekyan3, Ashutosh Tamhane3, Laura B. Hughes4, Jeremy Sokolove5, William H. Robinson6, Doyt L. Conn7, Beth L. Jonas8, Leigh F. Callahan9, Larry W. Moreland10, Richard D. Brasington11, Edwin A. Smith12, Ted R. Mikuls13, Désirée van der Heijde14 and S. Louis Bridges Jr.15, 1Med/Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 2Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4Med Div of Clin Imm & Rheum, University of Alabama at Birmingham, Birmingham, AL, 5VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 6Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 7Rheumatology, Emory Univ School of Medicine, Atlanta, GA, 8Thurston Arthritis Research Ct, University of North Carolina at Chapel Hill, Chapel Hill, NC, 9Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC, 10Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 11Div of Rheumatology, Washington Univ School of Med, St. Louis, MO, 12Dept of Med Div of Rheum, Med Univ of South Carolina, Charleston, SC, 13Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 14Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 15Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: anti-citrullinated protein/peptide antibodies (ACPA), joint damage and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Human Etiology and Pathogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Joint erosions and joint space narrowing may lead to impaired functional status and disability in rheumatoid arthritis (RA).  Autoantibodies to citrullinated proteins (ACPA) are present in RA sera, but the contribution of different specificities of ACPA to radiographic damage has not been studied. The objectives of this cross-sectional study were: to test the hypothesis that particular ACPA specificities are associated with radiographic damage in African-Americans with RA.

Methods:   Using a custom Bio-Plex™ bead-based autoantibody assay platform, we measured serum (N = 730 RA patients) concentration of antibodies targeting putative RA associated hyper-citrullinated autoantigens [vimentin, fibrinogen, histone 2A (H2A), histone 2B (H2B), and apolipoprotein A1 (Apo A1)] and their constitutively citrullinated forms.   Radiographic severity was defined as total Sharp/van der Heijde scores of hands/feet. Three negative binomial regression models of radiographic severity were fit: 1) conditional on sex, smoking, disease duration, BMI and ln(CCP), 2) Model 1 + each autoantibody, and 3) Model 2 without ln(CCP).  A highly conservative Bonferroni corrected alpha level of 0.005 for testing the autoantibodies was used.

Results:   Significant covariates from Model 1 included positive association of radiographic damage with disease duration and ln(CCP) (Table). In addition there was a weaker negative association of joint damage and body mass index (BMI).  Results for model 2 demonstrated significant associations of antibodies against native H2A, while antibodies against vimentin and histone 2B were nearly significant. There were no statistically significant associations between total radiographic score and antibodies to the hyper-citrullinated proteins. Results from Model 3 demonstrated that the associations between joint damage and the antibodies against native and hyper-citrullinated proteins were slightly stronger if anti-CCP antibodies were not taken into account.  The antibodies against native H2A, H2B, and vimentin remained statistically significantly associated with radiographic severity, but none of the antibodies against hyper-citrullinated proteins attained significance. 

Conclusion:  Autoantibodies against hyper- citrullinated proteins vimentin, fibrinogen, ApoA1, H2A and H2B were not associated with joint damage.   However, for African-Americans with established RA, antibodies to constitutively citrullinated proteins are most strongly associated with radiographic damage. 

Table.  Estimated parameters and negative binomial model fit statistics for the covariates and the natural logarithm of antibody concentrations given the covariates. 

Model 1

 

 

 

 

 

 

 

Variable

Estimate

p

 

Intercept

1.3

0.00073

Sex(Male)

0.19

0.39

 

Smoking(Never)

0.25

0.09

 

Disease duration

0.095

2.00E-16

 

BMI

-0.019

0.043

 

ln(CCP)

0.14

6.60E-07

 

Model 2

 

Constitutive

Estimate

p

Citrullinated

Estimate

p

 

Fibrinogen

0.29

0.082

Fibrinogen

-0.028

0.65

 

Vimentin

0.27

0.0067

Vimentin

0.014

0.77

 

Histone 2B

0.32

0.0073

Histone 2B

-0.079

0.17

 

Apolipoprotein A1

0.34

0.11

Apolipoprotein A1

0.022

0.71

 

Histone 2A

0.49

0.0018

Histone 2A

-0.085

0.11

 

Model 3

 

 

 

 

 

 

 

Constitutive

Estimate

p

 

Citrullinated

Estimate

p

 

Fibrinogen

0.37

0.029

 

Fibrinogen

0.07

0.2111

 

Vimentin

0.31

0.00256

 

Vimentin

0.087

0.033

 

Histone 2B

0.4

0.00057

 

Histone 2B

0.064

0.14

 

Apolipoprotein A1

0.44

0.042

 

Apolipoprotein A1

0.098

0.064

 

Histone 2A

0.58

0.00019

 

Histone 2A

0.051

0.2

 


Disclosure:

M. I. Danila,
None;

R. J. Reynolds,
None;

S. Aslibekyan,
None;

A. Tamhane,
None;

L. B. Hughes,
None;

J. Sokolove,
None;

W. H. Robinson,
None;

D. L. Conn,
None;

B. L. Jonas,
None;

L. F. Callahan,
None;

L. W. Moreland,
None;

R. D. Brasington,

Pfizer ,

5,

Human Genome Sciences,

2;

E. A. Smith,
None;

T. R. Mikuls,
None;

D. van der Heijde,
None;

S. L. Bridges Jr.,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-relationship-between-anti-citrullinated-protein-antibodies-and-radiographic-damage-in-african-americans-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology